172 related articles for article (PubMed ID: 28154177)
21. Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
Zhang X; Pan C; Zhou L; Cai Z; Zhao S; Yu D
BMC Cancer; 2016 Dec; 16(1):949. PubMed ID: 27986075
[TBL] [Abstract][Full Text] [Related]
22. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor.
Liu Z; Swindall AF; Kesterson RA; Schoeb TR; Bullard DC; Bellis SL
J Biol Chem; 2011 Nov; 286(45):39654-62. PubMed ID: 21930713
[TBL] [Abstract][Full Text] [Related]
23. ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway.
Chen X; Wang L; Zhao Y; Yuan S; Wu Q; Zhu X; Niang B; Wang S; Zhang J
Oncotarget; 2016 Aug; 7(32):51955-51964. PubMed ID: 27340870
[TBL] [Abstract][Full Text] [Related]
24. The structure of human α-2,6-sialyltransferase reveals the binding mode of complex glycans.
Kuhn B; Benz J; Greif M; Engel AM; Sobek H; Rudolph MG
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1826-38. PubMed ID: 23999306
[TBL] [Abstract][Full Text] [Related]
25. Systemic ST6Gal-1 Is a Pro-survival Factor for Murine Transitional B Cells.
Irons EE; Lau JTY
Front Immunol; 2018; 9():2150. PubMed ID: 30294329
[TBL] [Abstract][Full Text] [Related]
26. Sialylation of FGFR1 by ST6Gal‑I overexpression contributes to ovarian cancer cell migration and chemoresistance.
Ou L; He X; Liu N; Song Y; Li J; Gao L; Huang X; Deng Z; Wang X; Lin S
Mol Med Rep; 2020 Mar; 21(3):1449-1460. PubMed ID: 32016470
[TBL] [Abstract][Full Text] [Related]
27. Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
Smithson M; Irwin R; Williams G; Alexander KL; Smythies LE; Nearing M; McLeod MC; Al Diffalha S; Bellis SL; Hardiman KM
J Biol Chem; 2022 Mar; 298(3):101594. PubMed ID: 35041825
[TBL] [Abstract][Full Text] [Related]
28. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms.
Shaikh FM; Seales EC; Clem WC; Hennessy KM; Zhuo Y; Bellis SL
Exp Cell Res; 2008 Oct; 314(16):2941-50. PubMed ID: 18703050
[TBL] [Abstract][Full Text] [Related]
29. Biosynthesis of the cancer-related sialyl-alpha 2,6-lactosaminyl epitope in colon cancer cell lines expressing beta-galactoside alpha 2,6-sialyltransferase under a constitutive promoter.
Dall'Olio F; Chiricolo M; Mariani E; Facchini A
Eur J Biochem; 2001 Nov; 268(22):5876-84. PubMed ID: 11722575
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of ST6Gal-I inhibits the growth and invasion of osteosarcoma MG-63 cells.
Meng Q; Ren C; Wang L; Zhao Y; Wang S
Biomed Pharmacother; 2015 May; 72():172-8. PubMed ID: 26054692
[TBL] [Abstract][Full Text] [Related]
31. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.
Dougher CWL; Buffone A; Nemeth MJ; Nasirikenari M; Irons EE; Bogner PN; Lau JTY
J Leukoc Biol; 2017 Aug; 102(2):507-516. PubMed ID: 28550122
[TBL] [Abstract][Full Text] [Related]
32. Caveolin-1 up-regulates ST6Gal-I to promote the adhesive capability of mouse hepatocarcinoma cells to fibronectin via FAK-mediated adhesion signaling.
Yu S; Zhang L; Li N; Fan J; Liu L; Zhang J; Wang S
Biochem Biophys Res Commun; 2012 Oct; 427(3):506-12. PubMed ID: 23022190
[TBL] [Abstract][Full Text] [Related]
33. ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.
Swindall AF; Londoño-Joshi AI; Schultz MJ; Fineberg N; Buchsbaum DJ; Bellis SL
Cancer Res; 2013 Apr; 73(7):2368-78. PubMed ID: 23358684
[TBL] [Abstract][Full Text] [Related]
34. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
Seales EC; Jurado GA; Brunson BA; Wakefield JK; Frost AR; Bellis SL
Cancer Res; 2005 Jun; 65(11):4645-52. PubMed ID: 15930282
[TBL] [Abstract][Full Text] [Related]
35. ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma.
Liu HO; Wu Q; Liu WS; Liu YD; Fu Q; Zhang WJ; Xu L; Xu JJ
Asian Pac J Cancer Prev; 2014; 15(23):10217-23. PubMed ID: 25556450
[TBL] [Abstract][Full Text] [Related]
36. The generation of influenza-specific humoral responses is impaired in ST6Gal I-deficient mice.
Zeng J; Joo HM; Rajini B; Wrammert JP; Sangster MY; Onami TM
J Immunol; 2009 Apr; 182(8):4721-7. PubMed ID: 19342648
[TBL] [Abstract][Full Text] [Related]
37. Biologic contribution of P1 promoter-mediated expression of ST6Gal I sialyltransferase.
Appenheimer MM; Huang RY; Chandrasekaran EV; Dalziel M; Hu YP; Soloway PD; Wuensch SA; Matta KL; Lau JT
Glycobiology; 2003 Aug; 13(8):591-600. PubMed ID: 12672700
[TBL] [Abstract][Full Text] [Related]
38. Identification and functional expression of a second human beta-galactoside alpha2,6-sialyltransferase, ST6Gal II.
Krzewinski-Recchi MA; Julien S; Juliant S; Teintenier-Lelièvre M; Samyn-Petit B; Montiel MD; Mir AM; Cerutti M; Harduin-Lepers A; Delannoy P
Eur J Biochem; 2003 Mar; 270(5):950-61. PubMed ID: 12603328
[TBL] [Abstract][Full Text] [Related]
39. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
40. Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis.
Jones MB; Nasirikenari M; Feng L; Migliore MT; Choi KS; Kazim L; Lau JT
J Biol Chem; 2010 Aug; 285(32):25009-17. PubMed ID: 20529847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
